Fig. 3From: All-in-one theranostic nano-platform based on polymer nanoparticles for BRET/FRET-initiated bioluminescence imaging and synergistically anti-inflammatory therapy for ulcerative colitis BRET-FRET progress was evaluated in vitro and in vivo. AÂ The excitation and emission spectra of luminol, DiL, and DiD. BÂ The fluorescence spectra of BA/Res@NP-PBP at different concentrations of DiL. CÂ Fluorescence spectra of BA/Res@NP-PBP with different DiL and DiD proportions. DÂ Fluorescence spectra of BA/Res@NP-PBP with different total concentration. EÂ Images of DiL/DiD-loaded BA/Res@NP-PBP under a confocal microscope. FÂ Histogram of bioluminescence intensity statistics under different excitation lights. GÂ The changes of luminescence emission with the dose of luminol. HÂ The changes of luminescence emission with the dose of DiL/DiD-loaded BA/Res@NP-PBP. IÂ The changes of luminescence emission with the changes of the time point. JÂ Bioluminescence images of mice from different treatment groups. KÂ Histogram statistics of bioluminescence images. *p < 0.05, **p < 0.01, and ***p < 0.001Back to article page